THC Therapeutics(THCT)
$0.00+0.00 (+75.00%)
THCT
THC Therapeutics financials statements
$0.00
At close:+0.00 (+75.00%)
THC Therapeutics (THCT) Income Statement
33 Followers
THC Therapeutics Income Statement
Last quarter (Q3 2024), THC Therapeutics's total revenue was $0.00. In Q3, THC Therapeutics's net income was $104.62K. See THC Therapeutics’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Jul 23 | Jul 22 | Jul 21 | Jul 20 | Jul 19 |
|---|---|---|---|---|---|
| $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | |
| $ -1.39K | $ -12.33K | $ -16.37K | $ -20.11K | $ -25.56K | |
| $ 493.91K | $ 1.75M | $ 939.98K | $ 1.32M | $ 24.26M | |
| Depreciation and Amortization | $ 1.39K | $ 12.33K | $ 16.37K | $ 20.11K | $ 25.56K |
| $ -492.52K | $ -1.73M | $ -923.61K | $ -1.37M | $ -24.23M | |
| $ -493.91K | $ -1.75M | $ -939.98K | $ -1.32M | $ -26.69M | |
| $ 106.88K | $ 227.10K | $ -945.47K | $ -540.99K | $ 3.38M | |
| $ -387.04K | $ -1.52M | $ -1.89M | $ -1.93M | $ -23.31M | |
| $ -387.04K | $ -1.52M | $ -1.89M | $ -1.93M | $ -23.61M | |
| Per Share Metrics | |||||
| Basic EPS | $ -0.01 | $ -0.05 | $ -0.08 | $ -0.15 | $ -1.77 |
| Diluted EPS | $ -0.01 | $ -0.05 | $ -0.08 | $ -0.15 | $ -1.77 |
| Weighted Average Shares Outstanding | 32.81M | 33.24M | 23.66M | 16.55M | 13.38M |
| Weighted Average Shares Outstanding (Diluted) | 32.81M | 33.24M | 23.66M | 16.55M | 13.38M |
Currency in USD
